Publikační činnost

Přednášky

Každoročně aktivní účasti na odborných konferencích v České republice, popřípadě v zahraničí.

 

Publikace

Kapitoly v knihách (Chapters in Books)

  1. Blatný J., Mathew P. “Immune tolerance induction programs” pg 91-96 in Current and Future Issues in Haemophilia Care, edited by E.C Rodriguez-Merchand and L. Valentino, Willey-Blackwell, 2011,
  2. Blatný J. “Reference ranges of blood count and coagulation assays in children“ (Referenční meze krevního obrazu a koagulačních testů u dětí), pg. 160-162,  Inherited coagulation disorders in children (Vrozené krvácivé stavy – Pediatrickýdodatek), pg. 250-251,  Thrombophilia risk factors in paediatrics (Trombofílie – Pediatrický dodatek), pg. 255-256. In Penka M., Tesařová E et al., Haematology and Tranfusion Medicine (Hematologie a transfuzní lékařství I). 1st Edition, Grada, 2011. ISBN 978-80-247-3459-0.
  3. Blatný, J. “Coagulation disorders and principles of haemotherapy in oncology” (Poruchy koagulace a základní principy hemoterapie v onkologii.) in Adam, Z., Krejčí, M., Vorlíček, J. General Oncology (Obecná onkologie). 1st Edition, Galén, 2011. pg. 179-202, ISBN 9788072627158
  4. Blatný J. “Life Threatening bleeding” (Život ohrožující krvácení), Péče o kriticky nemocné dítě (textbook), Fendrychova J, Klimovič M et al., NCO NZO Brno 2005, ISBN 80-7013-427-5, pg. 183-187.
  5. Blatný J., “Inherited coagulation disorders” (Vrozené trombofilní stavy); Paediatric Haematology (Dětská hematologie) J. Starý et. al., Galén 2005 (edition Trendy v medicíně), ISBN 80-7262-327-3.,pg. 189-203

 

Recenzované zahraniční časopisy (Peer reviewed international journals)

  1. Pospisilova D, Cmejlova J, Ludikova B, Stary J, Cerna Z, Hak J, Timr P, Petrtylova K, Blatný J, Vokurka S, Cmejla R. The Czech National Diamond-Blackfan Anemia Registry: Clinical data and ribosomal protein mutations update. Blood Cells Mol Dis. 2012 Apr 15;48(4):209-18. Epub 2012 Mar 3.
  2. Fiamoli V. and Blatný J, Zapletal O, Kohlerova S, Janousova E.Treatment of Deep Vein Thrombosis with Continuous IV Infusion of LMWH: A Retrospective Study in 32 Children, Thrombosis. 2011;2011: 981497. Epub 2011 Apr 14
  3. Cmejla R, Ludikova B, Sukova M, Blatný J, Pospisilova D., Can mutations in the ribosomal protein S26 (RPS26) gene lead to Klippel-Feil syndrome in Diamond-Blackfananemia patients? An update from the Czech Diamond-Blackfan Anemia registry, Blood Cells Mol Dis. 2011 Apr 15;46(4):300-1.
  4. Samková A., Blatný J., Fiamoli V., Duliček P. and Pařízková E., Significance and causes of abnormal preoperative coagulation test results in children. Haemophilia. doi: 10.1111/j.1365-2516.2011.02665.x, (EPub ahead of print)
  5. J. Blatný, D. Seidlová, M. Penka, P. Ovesná, P. Brabec, P. Ševčík, P. Ventruba, V. Černý, Severe postpartum haemorrhage treated with recombinant activated Factor VII in 80 Czech patients: analysis of the UniSeven registry, International Journal of Obstetric Anesthesia October 2011(Vol. 20, Issue 4,Pages 367-368)
  6. Krenova Z, Kren L, Blatný J, Falk M, Kazakov DV, Grossmann P, Shimada H, Sterba J. Extraosseal Ewing sarcoma as a rare cause of the blueberry muffin baby syndrome: a case report and the review of the literature.Am J Dermatopathol. 2011 Oct; 33(7):733-5.
  7. Skoloudík D, Fadrná T, Roubec M, Bar M, Zapletal O, Blatný J, Langová K, Bardon P, Sanák D, Kanovský P, Herzig R., Changes in hemocoagulation in acute stroke patients after one-hour sono-thrombolysis using a diagnostic probe., Ultrasound Med Biol. 2010 Jul;36(7):1052-9.
  8. Puetz J, Darling G, Brabec P, Blatný J, Mathew P. Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. Pediatr Blood Cancer. 2009 Dec; 53(6):1074-8.
  9. Blatný J., Fiamoli V. Treatment of deep vein thrombosis with continuous intravenous infusion of LMWH in children-an alternative to subcutaneous application when needed. VnitrLek. 2009 Mar;55(3):227-32.
  10. Crushell E, Chukwu J, Mayne P, Blatný J, Treacy EP. Negative screening tests in classical galactosaemia caused by S135L homozygosity. J Inherit Metab Dis. 2009 Jun;32(3):412-5..
  11. Borska P, Faldyna M, Blatný J, Leva L, Vejrostova M, Doubek J, Moore PF. Gamma/delta T-cell lymphoma in a dog. Can Vet J. 2009 Apr; 50(4):411-6.
  12. Puetz J, Darling G, Brabec P, Blatný J, Mathew P. Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. Pediatr Blood Cancer. 2009 Dec; 53(6):1074-8.
  13. K Beel, M M. Cotter, J Blatný, J Bond, G Lucas, F Green, V Vanduppen, D W. Leung, S Rooney, O P. Smith, M K. Rosen and P Vandenberghe. A large kindred with X-linked neutropenia with an I294T mutation of the Wiskott-Aldrich syndrome gene British Journal of Haematology 2008, 144, 120–126
  14. Blatný J., Kohlerova S., Zapletal O., Fiamoli V., Penka M., Smith O. Prophylaxis with recombinant factor VIIa for the management of bleeding episodes during immune tolerance treatment in a boy with severe haemophilia A and inhibitors. . Haemophilia 2008 Sep; 14(5):1140-2.
  15. Krenova Z, Sterba J, Blatný J, Kren L, Slany J., A case of anaplastic large cell lymphoma-induced hemophagocyticlymphohistiocytosis in an adolescent female. Pediatr Blood Cancer. 2007 Dec; 49(7):1056.
  16. M. Morfini, G. Aeurswald, R. A. Kobelt, G. F. Rivolta, J. Rodriguez-Martorell, F. A. ScaraggiI, C. Altisent, J. Blatný, A. Borel-Delron and V. Rossi. Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres. Haemophilia (2007), Sep;13(5):502-7.
  17. Skoloudi­k D, Fadrna T, Bar M, Zapletalova O, Zapletal O, Blatný J, Penka M, Langova K, Hluštik P, Herzig R, Kanovsky P. Changes in haemocoagulation in healthy volunteers after a 1-hour thrombotripsy using a diagnostic 2-4 MHz transcranial probe.  J Thromb Thrombolysis. 2008 Oct;26(2):119-24
  18. Kotlin R., Chytilova M., Suttnar J., Riedel T. Salaj P., Blatný J., Santrucek J., Klener P., Dyr JE. Fibrinogen NovyJicin and Praha II: Cases of hereditary Aalpha  16ArgCysAalpha 16 Arg His dysfibrinogenemia. Thromb Res 2007 121(1):75-84.
  19. vonDepka M, Hassan M, Blatný J, Smejkal P, Vdovin V. The use of recombinant-activated factor VII in von Willebrand disease: a case series.Blood Coagul Fibrinolysis.2006 Jun;17(4):311-316.
  20. Sterba J, Prochazka J, Ventruba J, Kren L, Valik D, Burgetova D, Mudry P, Skotakova J, Blatny J.; Successful treatment of Aspergillus brain abscess in a child with acute lymphoblastic leukemia and liver failure. PediatrHematolOncol. 2005 Dec;22(8):649-55.
  21. Mike A. Laffan, R. Campbell Tait, Jan Blatný, Kurt Espersen, Izebelle Grabowska, Lidia Loch-Bakonska, Agata Pauzkowska, Elzbieta Stasiak-Pikula, Grazyna Michalska, Julia Wendon and Katarzyna Piotrowska, Use of Recombinant Activated Factor VII for Bleeding in Pancreatitis, A Case Series; Pancreas (2005) Vol. 30, 3: 279-284
  22. Blatný J., Dušek L., Štěrba J., Penka M., Risk Factors of Severe Complications Associated with Central Venous Lines in Children Treated for Malignant Disease – Prediction in Risk Analysis; SCRIPTA MEDICA (BRNO)–77 (3):145 –166,June 2004
  23. Doležel Z., Dostálková D., Blatný J., Starha J., Geryková H. Paroxysmal nocturnal hemoglobinuria in a girl with hemolysis and “hematuria”. PediatrNeprol (2004) 19:1177-1179
  24. Jarosova M, Holzerova M, Mihal V, Blatný J, Lakoma I, Trka J, Pikalova Z, Hrušák O, Indrak K, Additional evidence of genetic changes in children with ALL and TEL/AML1 fusion gene.Leukemia. 2002 Sep;16(9):1873-5.

 

Recenzované českéčasopisy (Peer reviewed Czech journals)

  1. Blatný J.  When to investigate for thrombophilia risk factors  in children (Kdyvyšetřovatvrozenátrombofilnírizika u dětí?). Československápediatrie. 2012: 67, (1), pg. 60-63.
  2. Blatný J., Blažek B., Recombinant factor concentrates in the treatment of haemophilia (Rekombinantní faktory krevního srážení v léčbě hemofilie), Postgraduální medicína 2012:14, (2), pg. 211 - 214
  3. Zdráhalová K., Sedláček P., Smíšek P., Keslová P., Štěrba J., Hrstková H., Blažek B., Mihál V., Hak J., Procházková D., Černá Z., Timr P., Zemanová Z.,Jarošová M., Oltová A., Schwarz J., Pospíšilová Š., Mejstříková E., Hrušák O., Zuna J., Vodičková E., Zámková A., Blatný J., Zapletal O.,  et al. Study Relapsed AML 2001/01,02 increased the chance for cure of children with relapsed AML or with primary resistent disease (Léčebnástudie Relapsed AML 2001/01,02 pro děti s relapsem akutní myeloidní leukemie nebo primárně rezistentní nemocí zlepšila jejic hnaději na vyléčení). Transfuze a hematologiednes. 2011:17(3), pg.
  4. O. Zapletal, J. Blatný, J. Štarha, Heparin-induces thrombocytopenia during the treatment with LMWH in children (Heparinem indukovaná trombocytopenie při léčbě nízkomolekulárními hepariny u dětí.) Vnitř. Lék 2010: 56 (suppl 1);
  5. Hofírek I., Penka M., Zvarová M., Šárník S., Blatný J., Zapletal O., Rotnágl J., Sochor O., Localized intravenous thrombolysis in children and adolescents (Lokálníintravenóznítrombolýza u dětí a mladistvích,) Vnitř. Lék 2010:56 (suppl 1)
  6. Fiamoli V., Blatný J., Chronic Immune Thrombocytopenic Purpura – successful treatment with antiCD20 (Chronická imunitní trombocytopenická purpura – úspěšná léčba protilátkami anti-CD20,) Vnitř. Lék 2010:56 (suppl 1)
  7. Blatný J., Štěrba J., Penka M., Sokolovská J.  Central venous lines (CVL) and thrombosis, not only in children with malignancy; Voxpediatriae 20004 (5) :pg:33-36
  8. Ošlejšková H., Šlapal R., Procházka J., Blatný J., Macků M., Habanec T., Racek P.: Isolated Cerebral Vasculitis in Five Years Old Girl, (Izolovaná cerebrální vaskulitida u pětiletédívky) Trendy v medicíně,  2000 :2v, (5), pg. 65-67
  9. ELukáš Z., Blatný J., Litzmann J., et al. :Diagnosis of CoeliacalSprue (Diagnostika celiakie) , Česko-Slovenskápediatrie, 1999:54,(10), pg. 566-8
  10. Slavíčková, J. Blatný, I. Melichar, E. Bajerová, Our Experience with Transfusion of Autologous Blood in Children (Naše zkušenost s autologní transfuzí u dětí) ;Transfuzednes; 1998:23, pg 22-.26

 

Abstracts, international journals

  1. Zapletal O., Blatný J., Fiamoli V., Köhlerová S., Retrospective assessment of risk factors for VTE in adolescents of south Moravian region, Czech Republic within years 2004-2010; Haematologica 2011; vol. 96, (sup 2) p.661, 
  2. Fiamoli V., Blatný J., Zapletal O., Köhlerová S., Chronic ITP – Case reports of the treatment by trombopoetin analogues in two children; Haematologica 2011; vol. 96, (sup 2) p. 647-648,
  3. Jan Blatny, Prasad Mathew, John Puetz, Petra Ovesna, and PetrBrabecSeveNBleeP Registry – 5 Years Later: An Update. Blood (ASH Annual Meeting Abstracts), Nov 2010; 116: Abstract 3651
  4. V. Fiamoli, J. Blatný:  Tretament of deep vein thrombosis with continuous iv infusion of LMWH in children in the years 2003-June 2009, Hematologica 2010;95 (s2) p. 67
  5. V. Fiamoli, J. Blatný, O. Zapletal, S. Kohlerova; Is it possible to treat safely and effectively deep vein thrombosis with continuous infusion of LMWH in children?; Journal of Tromb and Haemost., 2007; 5, Suppl 2, [P-S-584]
  6. J. Blatný, P. Mathew, J. Puetz.First interim analysis of SeveNBleeP registry focused on efficacy and safety of the treatment with rFVIIa in massive haemorrhage in chidlren, Journal of Tromb and Haemost., 2007; 5, Suppl 2, [P-S-234]
  7. J. Blatný, S. Kohlerova, O. Zapletal, V. Fiamoli, M. Penka.rFVIIa is effective alternative to aPCC in prophylaxis of bleeding during immune tolerance protocol in haemophiliac with inhibitor, Journal of Tromb and Haemost., 2007; 5, Suppl 2, [P-M-166]

  8. Penka, M, Mužík, J, Dušek, L, Blatný J, Smejkal, P, Komrska, V, Salaj, P, Klimeš, D, Šnábl, I, Matýškova, M, Pták, J, Hrachovinová, I, Ptoszková, H, Blažek, B, Buliková, A, Krčová, V; Project HemIS (Haemophilia –Information System): Multicentric Information System of Patients with Haemophilia, Journal of Thrombosis and Haemostasis 2005; 3 (Suppl. 1): Abstract (P 1407).
  9. BlatnýJ ,Kohlerova, S , Komrska, V , Pospisilova, D , Blazek, B, Brauner, R , Chroust, K , Dusek, LBleeding Prophylaxis in Children with Haemophilia A/B Using Plasma-derived Concentrates Immunate/Immunine – Prospective SurveyJournal of Thrombosis and Haemostasis 2005; 3 (Suppl. 1): Abstract (P 1998).
     
  10. BlatnýJ,Cerny, V, Penka, M, Brabec, P, Dusek, L, Treatment of Life Threatening Bleeding with rFVIIa in 2001–2004 in Czech Republic. Presentation of 126 Cases with the Help of ‘UniSeven’ Registry, Journal of Thrombosis and Haemostasis 2005;3 (Suppl. 1): Abstract (P2032).
  11. Kohlerova S., Blatný J., Komrska V., Blazek B., Pospíšilova D. Prophylaxis of bleeding in children with haemophilia A/B with plasma derived concentrated Immunate/Immunine-the safe way to improvement of quality of life. Haemophilia(2004) 10(Suppl.3): 106-109
  12. Kohlerova S., Blatný J., Ptoszkova H., Komrska V., Timr P., Tousovska K. Summer recondition stays of children-haemophiliacs in the Czech Republic (1995-2003) Haemophilia(2004) 10(Suppl.3):38-45
  13. Penka M., Dušek L., Smejkal P., Blatný J., Matyskova M., Komrska V., Salaj P., Krcova K., Ptak J., Blazek B. Project  HemIS (Haemophilia-Information System): multicentric information system of evaluation of clinical data of patients with haemophilia. Haemophilia(2004) 10(Suppl.3):21-2
  14. Blatný J., Bulikova M., Penka M., Slechtova M., Smejkal P., Magnova O., Sterba J.; rFVIIaNovoSeven® - Hemostatic agent not only for hemophiliacs; Abstract P1127, Supplement to the Journal of Thrombosis and Haemostasis July 2003 (ISSN 1740 ­ 3340)
  15. Blatný J., Sterba J., Dusek L., Koptíková J., Kepák T., Penka M.;  Multi-diagnostic retrospective study of risk factors of thrombosis in children with cancer - is there a space for multivariate predictive modeling?Abstract P0832,  Supplement to the Journal of Thrombosis and Haemostasis July 2003 (ISSN 1740 ­ 3340)
  16. Blatný J., Sterba J., Magnova O., Treatment of Life-Threatening Bleeding Associated with Kassabach-Merrit Syndrome in an Infant Using rFVIIaNovoSeven® ; Thrombosis and Haemostasis, Suppl July 2001, Abstract CD 3418
     

CZ ENG DE

změnit velikost písma
Jihlavská 20, 625 00 Brno
 +420 532 231 111
 fnbrno@fnbrno.cz
NIAHOSM ISO 9001:2008 ISO 14001:2001